Prostate Cancer Treatment Market Size Worth USD 47.78 Billion by 2034 | CAGR: 10.9%

Prostate Cancer Treatment Market Size Worth USD 47.78 Billion by 2034 | CAGR: 10.9%


The prostate cancer treatment market size is expected to reach USD 47.78 billion by 2034, according to a new study by Polaris Market Research. The report “Prostate Cancer Treatment Market Size, Share, Trends, Industry Analysis Report: By Drug Class (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy, and Others), Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2026–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The prostate cancer treatment market growth is attributed to the rising prevalence of prostate cancer, especially among aging populations, and advancements in diagnostic and therapeutic technologies. Key drivers include the increasing adoption of precision medicine; the development of innovative therapies such as immunotherapy, targeted therapy, and radiopharmaceuticals; and the growing focus on early diagnosis and screening. Prostate cancer treatment market opportunities lie in the expansion of digital health solutions, including telemedicine and e-prescriptions, which improve patient accessibility to treatments. Trends such as the adoption of combination therapies and minimally invasive procedures and the use of biomarkers for personalized treatments are shaping the market’s future. As the global incidence of prostate cancer rises, the market is expected to grow significantly during the forecast period, with regions such as North America and Asia Pacific driving much of the expansion.

Prostate Cancer Treatment Market Report Highlights:

  • North America held the largest share of 42.0% in 2025. It is primarily driven by the high prevalence of prostate cancer and the presence of advanced healthcare infrastructure.
  • Asia Pacific is projected to witness rapid growth at a 13.20% CAGR. The growth is fueled by increasing healthcare investments and improved access to medical care.
  • The hormonal therapy segment held the largest revenue share of 54.0% in 2025. It is due to its widespread use as the first-line treatment for prostate cancer.
  • The hospital pharmacies segment dominated with a 52.0% market share in 2025. The leadership position is attributed to their role in facilitating access to specialized oncology treatments. 
  • The online pharmacies segment is projected to witness the highest growth rate of 14.60%. The segment’s growth is driven by increasing digitalization and a shift toward home-based healthcare solutions.

Request a free sample copy or read the full market insights :  prostate cancer treatment market Report

Polaris Market Research has segmented the prostate cancer treatment market report on the basis of drug class, distribution channel, and region:

By Drug Class Outlook (Revenue – USD Billion, 2021–2034)

  • Hormonal Therapy
  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy
  • Others

By Distribution Channel Outlook (Revenue – USD Billion, 2021–2034)

  • Hospital Pharmacies
  • Drug Stores & Retail Pharmacies
  • Online Pharmacies

By Regional Outlook (Revenue – USD Billion, 2021–2034)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Netherlands
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Malaysia
    • South Korea
    • Indonesia
    • Australia
    • Vietnam
    • Rest of Asia Pacific
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Israel
    • South Africa
    • Rest of Middle East & Africa
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Rest of Latin America

Prostate Cancer Treatment Market Report Scope

Report Attributes

Details

Market Size Value in 2025

USD 18.82 billion

Market Size Value in 2026

USD 20.83 billion

Revenue Forecast by 2034

USD 47.78 billion

CAGR

10.9% from 2026 to 2034

Base Year

2025

Historical Data

2021–2024

Forecast Period

2026–2034

Quantitative Units

Revenue in USD billion and CAGR from 2026 to 2034

Report Coverage

Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends

Segments Covered

  • By Drug Class
  • By Distribution Channel

Regional Scope

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Competitive Landscape

  • Prostate Cancer Treatment Industry Trends Analysis (2025)
  • Company Profiles/Industry participants profiling includes company overview, financial information, product/service benchmarking, and recent developments

Report Format

  • PDF + Excel

Customization

Report customization as per your requirements with respect to countries, regions, and segmentation.

For Specific Research Requirements Request Customization

Source: Polaris Market Research Analysis

Download Sample